Live Breaking News & Updates on Disease Programs

Stay updated with breaking news from Disease programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Joern Aldag , Michael Kaiser , Mark Winderlich , Exchange Commission , Company On , Pharma Inc , Company Type , European Medicines Agency , Development Expenses , Gilead Sciences Inc , Drug Administration , Reports First Quarter , Recent Business , Priority Medicines , Investigational New Drug , Chief Development Officer , Chief Executive Officer , Human Papillomavirus , Gilead Sciences , Financial Updates , Disease Programs , Administrative Expenses , Private Securities Litigation Reform Act ,

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Lexeo announces $95.0M equity financing, which in addition to 2023 year-end cash and cash equivalents of $121.5M, extends runway to fund operations into 2027 Reports frataxin protein expression data. ....

New York , United States , Carolyn Hawley , Laurence Watts , R Nolan Townsend , Lexeo Therapeutics Inc , Exchange Commission , Program Updates , Globenewswire Inc , Nolan Townsend , Chief Executive Officer , Chromatography Mass Spectrometry , Assay Protein Expression , Fast Track , Orphan Drug , Disease Programs , Equity Financing , Initial Public Offering , Full Year Financial , York City Based , Quarterly Report , Safe Harbor , Private Securities Litigation Reform Act , Consolidated Statements ,

HOOKIPA Pharma (HOOK) Provides Update on Business Priorities and Oncology Partnership Programs

HOOKIPA Pharma (HOOK) Provides Update on Business Priorities and Oncology Partnership Programs
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joern Aldag , Hookipa Pharma Inc , Chief Executive Officer , Disease Programs ,

HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious disease HOOKIPA will regain global development. ....

Joern Aldag , Michael Kaiser , Pharma Inc , Exchange Commission , Investigational New Drug , Chief Executive Officer , Disease Programs , Human Papillomavirus , Private Securities Litigation Reform Act , Roche Collaboration Agreement ,

HOOKIPA Pharma Provides Update on Business Priorities and

HOOKIPA to prioritize clinical development of HB-200 for the treatment of HPV16+ head and neck cancers and Gilead-partnered programs in infectious. ....

Michael Kaiser , Joern Aldag , Pharma Inc , Exchange Commission , Investigational New Drug , Chief Executive Officer , Disease Programs , Human Papillomavirus , Private Securities Litigation Reform Act , Roche Collaboration Agreement , Nasdaq Hook , Hookipa Pharma Inc , Hookipa Pharma , Sb 200 , Head And Neck Cancer ,